These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1986724)

  • 21. The role of microvascular injury in the pathogenesis of cutaneous lesions of dermatomyositis.
    Crowson AN; Magro CM
    Hum Pathol; 1996 Jan; 27(1):15-9. PubMed ID: 8543305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What more can we learn from muscle histopathology in children with dermatomyositis/polymyositis?
    Wargula JC; Lovell DJ; Passo MH; Bove KE; Santangelo JD; Levinson JE
    Clin Exp Rheumatol; 2006; 24(3):333-43. PubMed ID: 16870106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between capillary and muscle damage in dermatomyositis.
    Casademont J; Grau JM; Estruch R; Pedro-Botet JC; Urbano-Márquez A
    Int J Dermatol; 1990 Mar; 29(2):117-20. PubMed ID: 2323864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The clinical and muscular pathological study of dermatomyositis with perifascicular atrophy changes].
    Liu Z; Chen L; Guo YP; Ren HT; Zhao YH
    Zhonghua Nei Ke Za Zhi; 2012 Sep; 51(9):698-701. PubMed ID: 23158920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of the membrane attack complex as a diagnostic tool in dermatomyositis.
    Jain A; Sharma MC; Sarkar C; Bhatia R; Singh S; Gulati S; Handa R
    Acta Neurol Scand; 2011 Feb; 123(2):122-9. PubMed ID: 20497129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Terbinafine-induced dermatomyositis: a case report and literature review of drug-induced dermatomyositis.
    Magro CM; Schaefer JT; Waldman J; Knight D; Seilstad K; Hearne D
    J Cutan Pathol; 2008 Jan; 35(1):74-81. PubMed ID: 18096000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Whole microvascular unit deletions in dermatomyositis.
    Gitiaux C; Kostallari E; Lafuste P; Authier FJ; Christov C; Gherardi RK
    Ann Rheum Dis; 2013 Mar; 72(3):445-52. PubMed ID: 22962315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patients with polymyositis and dermatomyositis who undergo plasmapheresis therapy. Pathologic findings.
    Bennington JL; Dau PC
    Arch Neurol; 1981 Sep; 38(9):553-60. PubMed ID: 7023435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hereditary complement (C9) deficiency associated with dermatomyositis.
    Ichikawa E; Furuta J; Kawachi Y; Imakado S; Otsuka F
    Br J Dermatol; 2001 May; 144(5):1080-3. PubMed ID: 11359403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultrastructural abnormalities and perifascicular atrophy in childhood dermatomyositis with special reference to transverse tubular system-sarcoplasmic reticulum junctions.
    Chou SM; Miike T
    Arch Pathol Lab Med; 1981 Feb; 105(2):76-85. PubMed ID: 6893922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunopathological changes of micro-vessels in dermatomyositis].
    Shen GL; Lü H; Bi HY; Zhang W; Yao S; Tu P; Yuan Y
    Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(27):1912-5. PubMed ID: 17064530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myositis in mixed connective tissue disease: a unique syndrome characterized by immunohistopathologic elements of both polymyositis and dermatomyositis.
    Vianna MA; Borges CT; Borba EF; Caleiro MT; Bonfá E; Marie SK
    Arq Neuropsiquiatr; 2004 Dec; 62(4):923-34. PubMed ID: 15608947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dermatomyositis].
    Stoltenburg-Didinger G; Genth E
    Z Rheumatol; 2009 Jun; 68(4):287-94. PubMed ID: 19330338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Complement activation products (C3a and C5b-9) as markers of activity of dermatomyositis. Comparison with usual biochemical parameters].
    Campo A; Hausmann G; Martí RM; Estrach T; Grau JM; Porcel JM; Herrero C
    Actas Dermosifiliogr; 2007; 98(6):403-14. PubMed ID: 17663930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ultrastructure of skeletal muscles in children with dermatomyositis].
    Sekamova SM; Kon'eva TN; Zhvaniia MA
    Arkh Patol; 1978; 40(2):56-65. PubMed ID: 646665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Small blood vessel involvement in childhood dermatomyositis. An ultrastructural study of a case.
    Ludatscher R; Gellei B; Guershoni G; Benderley A
    Isr J Med Sci; 1977 Jan; 13(1):20-5. PubMed ID: 838568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dermatomyositis-associated sensory neuropathy: a unifying pathogenic hypothesis.
    Nguyen TP; Bangert C; Biliciler S; Athar P; Sheikh K
    J Clin Neuromuscul Dis; 2014 Sep; 16(1):7-11. PubMed ID: 25137509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C4d staining as immunohistochemical marker in inflammatory myopathies.
    Pytel P
    Appl Immunohistochem Mol Morphol; 2014 Oct; 22(9):696-704. PubMed ID: 24897075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cutaneous lesions of dermatomyositis with supervening fibrosis.
    Magro CM; Dyrsen M; Kerns MJ
    J Cutan Pathol; 2008 Jan; 35(1):31-9. PubMed ID: 18095992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amyopathic dermatomyositis.
    Kagen LJ
    Arch Dermatol; 1995 Dec; 131(12):1458-9. PubMed ID: 7492141
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.